302 related articles for article (PubMed ID: 29365133)
1. Periprocedural myocardial infarction and injury in elective coronary stenting.
Zeitouni M; Silvain J; Guedeney P; Kerneis M; Yan Y; Overtchouk P; Barthelemy O; Hauguel-Moreau M; Choussat R; Helft G; Le Feuvre C; Collet JP; Montalescot G;
Eur Heart J; 2018 Apr; 39(13):1100-1109. PubMed ID: 29365133
[TBL] [Abstract][Full Text] [Related]
2. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
[TBL] [Abstract][Full Text] [Related]
3. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
[TBL] [Abstract][Full Text] [Related]
4. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
[TBL] [Abstract][Full Text] [Related]
5. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
Yang X; Tamez H; Lai C; Ho K; Cutlip D
Catheter Cardiovasc Interv; 2017 Apr; 89(5):849-856. PubMed ID: 27535209
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
Piccolo R; Leone A; Simonetti F; Avvedimento M; Angellotti D; Manzi L; Verde N; Spaccarotella CAM; Di Serafino L; Cirillo P; Gargiulo G; Fortunato G; Franzone A; Esposito G
Catheter Cardiovasc Interv; 2023 Aug; 102(2):212-220. PubMed ID: 37337462
[TBL] [Abstract][Full Text] [Related]
7. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
8. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.
Huang Z; Zhuang X; Zhang S; Huang Y; Yuan L; Lin A; Tang L; Xiong Z; Christopher O; Chen Y; Wu B; Ling Y; Li S; Jie Q; Xiong L; Qian X; Liao X; Liu J
BMJ Open; 2023 Jul; 13(7):e072541. PubMed ID: 37433737
[TBL] [Abstract][Full Text] [Related]
9. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Bulluck H; Paradies V; Barbato E; Baumbach A; Bøtker HE; Capodanno D; De Caterina R; Cavallini C; Davidson SM; Feldman DN; Ferdinandy P; Gili S; Gyöngyösi M; Kunadian V; Ooi SY; Madonna R; Marber M; Mehran R; Ndrepepa G; Perrino C; Schüpke S; Silvain J; Sluijter JPG; Tarantini G; Toth GG; Van Laake LW; von Birgelen C; Zeitouni M; Jaffe AS; Thygesen K; Hausenloy DJ
Eur Heart J; 2021 Jul; 42(27):2630-2642. PubMed ID: 34059914
[TBL] [Abstract][Full Text] [Related]
10. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
Stone GW; Maehara A; Muller JE; Rizik DG; Shunk KA; Ben-Yehuda O; Genereux P; Dressler O; Parvataneni R; Madden S; Shah P; Brilakis ES; Kini AS;
JACC Cardiovasc Interv; 2015 Jun; 8(7):927-36. PubMed ID: 26003018
[TBL] [Abstract][Full Text] [Related]
11. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
[TBL] [Abstract][Full Text] [Related]
13. Association of chronic kidney disease with periprocedural myocardial injury after elective stent implantation: A single center prospective cohort study.
Jerkic H; Letilovic T; Stipinovic M; Pocanic D; Catic J; Knotek M
Medicine (Baltimore); 2016 Nov; 95(45):e5381. PubMed ID: 27828870
[TBL] [Abstract][Full Text] [Related]
14. Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Chen A; Ma J; Dai C; Lu D; Wu Y; Li S; Chen J; Liu M; Li C; Lu H; Qian J; Ge J
Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):871-880. PubMed ID: 34962992
[TBL] [Abstract][Full Text] [Related]
15. Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.
Ueki Y; Otsuka T; Bär S; Koskinas KC; Heg D; Häner J; Siontis GCM; Praz F; Hunziker L; Lanz J; Stortecky S; Pilgrim T; Losdat S; Windecker S; Räber L
J Am Coll Cardiol; 2022 Feb; 79(6):513-526. PubMed ID: 35144742
[TBL] [Abstract][Full Text] [Related]
16. Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography.
Porto I; Di Vito L; Burzotta F; Niccoli G; Trani C; Leone AM; Biasucci LM; Vergallo R; Limbruno U; Crea F
Circ Cardiovasc Interv; 2012 Feb; 5(1):89-96, S1-6. PubMed ID: 22298799
[TBL] [Abstract][Full Text] [Related]
17. Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI.
Piccolo R; Leone A; Avvedimento M; Simonetti F; Ippolito D; Angellotti D; Verde N; Manzi L; Cirillo P; Serafino LD; Fortunato G; Franzone A; Esposito G
Eur Heart J Qual Care Clin Outcomes; 2023 Nov; 9(7):680-690. PubMed ID: 36385164
[TBL] [Abstract][Full Text] [Related]
18. Acute ischemic events are frequent after primary coronary stenting.
Kranjec I; Dzananovic DZ
J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):178-88. PubMed ID: 24978874
[TBL] [Abstract][Full Text] [Related]
19. Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention?
Tomaniak M; Kołtowski Ł; Kochman J; Huczek Z; Rdzanek A; Pietrasik A; Gasecka A; Gajda S; Opolski G; Filipiak KJ
Pol Arch Intern Med; 2017 Nov; 127(11):730-740. PubMed ID: 28817535
[TBL] [Abstract][Full Text] [Related]
20. Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation.
Osugi N; Suzuki S; Ishii H; Yasuda Y; Shibata Y; Tatami Y; Ota T; Kawamura Y; Okumura S; Tanaka A; Inoue Y; Matsuo S; Murohara T
Am J Cardiol; 2014 Jul; 114(1):42-6. PubMed ID: 24802297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
